Jazz Pharmaceuticals PLC
F:J7Z
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
J
|
Jazz Pharmaceuticals PLC
F:J7Z
|
IE |
|
Sunrun Inc
NASDAQ:RUN
|
US |
|
X
|
Xenia Hotels & Resorts Inc
F:0XHR
|
US |
|
Turquoise Hill Resources Ltd
TSX:TRQ
|
CA |
|
Hera SpA
OTC:HRASF
|
IT |
|
Research Solutions Inc
F:61I
|
US |
|
P
|
Precigen Inc
F:I5X
|
US |
|
R
|
Radcom Ltd
SWB:RAM
|
IL |
|
Rexel SA
F:E7V
|
FR |
|
C
|
Cardinal Infrastructure Group Inc
NASDAQ:CDNL
|
US |
|
L
|
L'Occitane International SA
XMUN:COC
|
LU |
Wall St Price Targets
J7Z Price Targets Summary
Jazz Pharmaceuticals PLC
According to Wall Street analysts, the average 1-year price target for J7Z is 128.29 EUR with a low forecast of 98.42 EUR and a high forecast of 152.94 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is J7Z's stock price target?
Price Target
128.29
EUR
According to Wall Street analysts, the average 1-year price target for J7Z is 128.29 EUR with a low forecast of 98.42 EUR and a high forecast of 152.94 EUR.
What is the Revenue forecast for Jazz Pharmaceuticals PLC?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 8 years is 5%.
What is the Operating Income forecast for Jazz Pharmaceuticals PLC?
Projected CAGR
22%
Over the last 13 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 8 years is 22%.
